Biden Says Covid Testing Funds Are Running Low

The transcript highlights the urgent need for congressional funding to continue the fight against COVID-19. It emphasizes the importance of monoclonal antibodies, preventive therapies for immunocompromised individuals, and maintaining testing capacity. Without additional funding, the supply of these critical tools will run out, leaving the country vulnerable to future virus waves.

Why is it crucial for Congress to provide funding for monoclonal antibodies?

• They are a partisan issue.

• They are essential for saving lives.

• They are not effective against COVID-19.

• They are only needed in certain states.

What is the consequence of not having enough funding for preventive therapies?

• Increased supply of therapies.

• No impact on immunocompromised individuals.

• Risk of running out of supply by fall.

• Immediate availability of therapies.

What challenge is faced in maintaining testing capacity?

• Lack of demand for tests.

• Sufficient funding is available.

• Inability to sustain capacity without funding.

• Tests are not needed for future waves.

What was learned from the Omicron surge regarding testing?

• Testing was only needed in some areas.

• Testing was vital to manage the surge.

• Testing capacity was irrelevant.

• Testing was not necessary.

What is the risk if there is no investment in testing?

• No risk at all.

• Increased vulnerability to future virus waves.

• Immediate end to the pandemic.

• Testing will become obsolete.